Gline Matthew
SEC insider (Form 3/4/5 filer). CIK 0001750094. CEO at Roivant Sciences Ltd. (ROIV) and 1 other issuer. 29 reported Form 4/5 transactions since Sep 2024; latest on Oct 16, 2026. Located in LONDON.
Companies Gline Matthew has filed insider reports for
- Roivant Sciences Ltd. (ROIV): Director, Officer, CEO
- Arbutus Biopharma Corp (ABUS): Director, 10% Owner
Gline Matthew
CIK: 0001750094
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Oct 16, 2026ROIV
Roivant Sciences Ltd.
Tax PaymentDirect34.6K shares at avg. $33.53$1.2M - Sep 30, 2026ROIV
Roivant Sciences Ltd.
Tax PaymentDirect76.2K shares at avg. $36.57$2.8M - Jun 30, 2026ROIV
Roivant Sciences Ltd.
Tax PaymentDirect76.2K shares at avg. $35.39$2.7M - Apr 16, 2026ROIV
Roivant Sciences Ltd.
SaleDirect289.8K shares at avg. $29.16$8.4M - Mar 31, 2026ROIV
Roivant Sciences Ltd.
Tax PaymentDirect304.7K shares at avg. $27.70$8.4M - Mar 30, 2026ROIV
Roivant Sciences Ltd.
ExerciseDirect97.3K shares- - Mar 30, 2026ROIV
Roivant Sciences Ltd.
Tax PaymentDirect53.8K shares at avg. $26.41$1.4M - Dec 15, 2025ROIV
Roivant Sciences Ltd.
ExerciseDirect2.3M shares at avg. $12.68$28.8M - Dec 15, 2025ROIV
Roivant Sciences Ltd.
OtherDirect797.6K shares at avg. $21.68$17.3M - Dec 15, 2025ROIV
Roivant Sciences Ltd.
OtherDirect3.7K shares at avg. $21.68$81K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 16, 2026 |  ROIV Roivant Sciences Ltd. | Tax Payment | 34,638 | $33.53 | $1,161,412 | Direct |
| Sep 30, 2026 | ROIV Roivant Sciences Ltd. | Tax Payment | 76,171 | $36.57 | $2,785,573 | Direct |
| Jun 30, 2026 | ROIV Roivant Sciences Ltd. | Tax Payment | 76,171 | $35.39 | $2,695,692 | Direct |
| Apr 16, 2026 | ROIV Roivant Sciences Ltd. | Sale | 289,774 | $29.16 | $8,449,810 | Direct |
| Mar 31, 2026 | ROIV Roivant Sciences Ltd. | Tax Payment | 304,684 | $27.70 | $8,439,747 | Direct |
| Mar 30, 2026 | ROIV Roivant Sciences Ltd. | Exercise | 97,319 | - | $0 | Direct |
| Mar 30, 2026 | ROIV Roivant Sciences Ltd. | Tax Payment | 53,826 | $26.41 | $1,421,545 | Direct |
| Dec 15, 2025 | ROIV Roivant Sciences Ltd. | Exercise | 2,272,852 | $12.68 | $28,819,763 | Direct |
| Dec 15, 2025 | ROIV Roivant Sciences Ltd. | Other | 797,595 | $21.68 | $17,291,860 | Direct |
| Dec 15, 2025 | ROIV Roivant Sciences Ltd. | Other | 3,739 | $21.68 | $81,062 | Direct |
1-10 of 29 transactions